Hypidone

Hypidone
	File:Hypidone structure.png
Clinical data
Other names	YL-0919; YL0919
Identifiers
	IUPAC name 1-[(1-benzyl-4-hydroxypiperidin-4-yl)methyl]pyridin-2-one;
CAS Number	1339339-18-2 ; 1339058-04-6 (HCl);
PubChem CID	54673543;
ChemSpider	68055492;
E number	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).;
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C18H22N2O2
Molar mass	298.386 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CN(CCC1(CN2C=CC=CC2=O)O)CC3=CC=CC=C3;
	InChI InChI=1S/C18H22N2O2/c21-17-8-4-5-11-20(17)15-18(22)9-12-19(13-10-18)14-16-6-2-1-3-7-16/h1-8,11,22H,9-10,12-15H2; Key:BGMVOROUOUVVRV-UHFFFAOYSA-N;

Hypidone (developmental code name YL-0919) is an investigational serotonergic antidepressant which is under development for the treatment of major depressive disorder.^[1]^[2]^[3]^[4]^[5] It acts as a serotonin reuptake inhibitor, 5-HT_1A receptor partial agonist, and 5-HT₆ receptor full agonist.^[1]^[5] It is used as the hydrochloride salt.^[2]^[5] As of January 2021, hypidone is in phase 2 clinical trials for major depressive disorder.^[1]

References

^ ^a ^b ^c Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
^ ^a ^b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
^ ^a ^b ^c Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.